Merit Medical Systems Inc insider trading
Every open-market purchase and sale by Merit Medical Systems Inc's officers, directors and largest shareholders since November 4, 2021, and what the share price did next.
| Date | Insider | Trade | Shares | Price | Value | 1M after | 3M after | 6M after |
|---|
Does following Merit Medical Systems Inc’s insiders pay?
From March 17, 2010 to August 25, 2026, 30 insiders reported 9 open-market purchases and 201 sales not made under a pre-set plan in Merit Medical Systems Inc. Twelve months after each purchase was reported, the shares were +16.1% against the S&P 500 on average (median +5.7%), over 4 purchases with a full year of prices; 50% beat the index. After sales, the shares moved −3.0% against the index over 12 months (a negative figure means selling was the right call). That rests on fewer than 20 purchases, too few to read much into. Buying each purchase the day after it was reported, an equal amount each, held 12 months or until that insider reported a sale, would have turned $10,000 on March 2, 2012 into $27,403 by November 2, 2026, +7.1% a year. It held shares 24% of the time; the S&P 500 on those same days, with Treasury bills otherwise, made $22,861 (+5.8% a year), and held throughout $71,089 (+14.3%).
| Insider | Role | Purchases | 12 months after their purchases | Beat the S&P 500 | Sales | 12 months after their sales | Latest report |
|---|---|---|---|---|---|---|---|
| Lampropoulos Fred P. | Executive Chairman | 0 | — | — | 28 | −6.6% (24) | November 26, 2025 |
| Miller Franklin J | Director | 0 | — | — | 15 | +3.1% (15) | March 13, 2020 |
| Parra Raul JR. | CFO AND TREASURER | 2 | +71.7% (1) | 100% | 13 | −18.6% (13) | May 7, 2026 |
| Stanger Kent W | Chief Financial Officer | 0 | — | — | 15 | +21.8% (15) | April 2, 2019 |
| Edelman Richard W | Other | 0 | — | — | 14 | +7.6% (14) | August 1, 2017 |
| Bean Rex C | Director | 0 | — | — | 13 | +5.5% (13) | May 23, 2013 |
| Frost Ronald | CHIEF OPERATING OFFICER | 1 | −3.3% (1) | 0% | 10 | −3.4% (10) | August 12, 2022 |
| Stillabower Michael E | Director | 0 | — | — | 11 | −4.4% (11) | August 6, 2019 |
| Karras Nolan E. | Director | 1 | −18.5% (1) | 0% | 8 | +8.7% (8) | May 29, 2020 |
| Anderson A Scott | Director | 0 | — | — | 8 | +15.8% (8) | August 11, 2023 |
| Barnett Greg L | Chief Accounting Officer | 0 | — | — | 8 | −15.0% (8) | August 3, 2015 |
| Perry Rashelle | Chief Legal Officer | 0 | — | — | 8 | −14.7% (8) | December 2, 2015 |
| Lloyd Brian G. | CHIEF LEGAL OFFICER, SECRETARY | 1 | — | — | 6 | −18.9% (6) | May 11, 2026 |
| Wright Joseph | CHIEF COMMERCIAL OFFICER | 0 | — | — | 7 | +3.2% (7) | March 8, 2024 |
| Peterson Neil W. | CHIEF OPERATING OFFICER | 0 | — | — | 6 | −10.3% (4) | August 25, 2026 |
| Millner F. Ann Ed.d. | Director | 0 | — | — | 5 | +4.3% (5) | June 7, 2022 |
| Stephens Martin R | Executive V.P. of Sales | 0 | — | — | 5 | −19.2% (5) | December 23, 2014 |
| Ward Lynne N. | Director | 0 | — | — | 5 | −18.8% (4) | May 11, 2026 |
| Lampropoulos Justin J. | PRESIDENT, EMEA | 0 | — | — | 4 | −27.1% (4) | March 16, 2021 |
| Voigt Michel J. | CHIEF HUMAN RESOURCES OFFICER | 1 | — | — | 2 | −38.7% (2) | May 7, 2026 |
| Ellis James J | Director | 0 | — | — | 2 | −36.1% (2) | April 19, 2011 |
| Evans Stephen C. | Director | 0 | — | — | 2 | −14.5% (2) | March 4, 2025 |
| Nelson Arlin D | Chief Operating Officer | 0 | — | — | 2 | −33.0% (2) | September 7, 2012 |
| Anderson Jill | Director | 0 | — | — | 1 | −5.8% (1) | September 13, 2021 |
| Aronson Martha Goldberg | President and CEO | 1 | — | — | 0 | — | May 7, 2026 |
| Birkett Bernard | Chief Financial Officer | 0 | — | — | 1 | +20.6% (1) | December 2, 2015 |
| Floyd David | Director | 1 | +14.6% (1) | 100% | 0 | — | August 6, 2020 |
| Gunderson Thomas J. | Director | 0 | — | — | 1 | +18.4% (1) | March 5, 2024 |
| Liu David Ming-Teh | Director | 0 | — | — | 1 | −0.6% (1) | June 3, 2020 |
| Smith Christian Adam | Chief Commercial Officer | 1 | — | — | 0 | — | May 13, 2026 |
When several insiders traded Merit Medical Systems Inc
Months when 2 or more insiders became net buyers, or 3 or more net sellers, of Merit Medical Systems Inc in reports dated in the 91 days before the month end, and how the stock did against the S&P 500 from that month end. After 19 selling crowds, −3.9%. One company's history is too short to judge by; the test across every company is the better guide.
| Month | Crowd | 3 months on, vs S&P 500 | 6 months | 12 months |
|---|---|---|---|---|
| May 29, 2026 | 5 buying | +41.5% | not yet | not yet |
| August 29, 2025 | 3 selling | −10.6% | −23.4% | −19.3% |
| March 31, 2025 | 5 selling | −21.8% | −41.0% | −53.9% |
| March 28, 2024 | 4 selling | +9.1% | +19.0% | +30.6% |
| March 31, 2023 | 6 selling | +2.8% | −14.2% | −30.2% |
| August 31, 2022 | 6 selling | +18.0% | +15.1% | −5.8% |
| September 30, 2021 | 5 selling | −22.2% | −13.3% | −5.8% |
| March 31, 2021 | 5 selling | −0.4% | +10.1% | −6.3% |
| March 31, 2020 | 3 selling | +25.9% | +7.8% | +35.4% |
| March 29, 2019 | 4 selling | −7.9% | −56.4% | −44.5% |
| November 30, 2018 | 3 selling | −12.4% | −17.8% | −70.1% |
| June 29, 2018 | 4 selling | +12.4% | +15.9% | +1.3% |